Colon Cancer and Other Gastrointestinal Malignancies

  • Walter B. Forman

Abstract

In the 1983 edition of Clinical Oncology,1 the authors note, “The outlook for the patient with any alimentary tract cancer is not very favorable...) and these cancers are mainly of surgical interest.” Although cancer of the gastrointestinal tract remains of surgical interest, strides in the understanding of natural history, early diagnosis/ treatment, and pathogenesis have brought cancers of the gastrointestinal tract into a new therapeutic realm. This chapter reviews the changes that have occurred in past 10 years in the diagnosis and treatment of these cancers, with particular emphasis on the current approach to treatment of cancer of the colon and rectum in the older person. Chapter 18 discusses the major impact on treatment that has come from advances in early diagnosis.

Keywords

Gastric Cancer Colorectal Cancer Pancreatic Cancer Gastrointestinal Malignancy Gastric Outlet Obstruction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rubbing P. Clinical Oncology: A Multidisciplinary Approach. New York: The American Cancer Society; 1983.Google Scholar
  2. 2.
    Steele GD, Osteen RT, Winchester DP, Menck HR, Murphy GP. National Cancer Data Base: Annual Review of Patient Care. Atlanta: The American Cancer Society; 1994.Google Scholar
  3. 3.
    McGregor RA, Bacon HE. Multiple cancers in colon surgery: report of 162 cases. Surgery. 1958; 44: 828–833.PubMedGoogle Scholar
  4. 4.
    Beahrs O, Henson D, Hutter R, et al. Manual for Staging of Cancer. 3rd ed. Philadelphia: JB Lippincott; 1988: 75–78.Google Scholar
  5. 5.
    McDermott FT, Hughes ESR, Paihl E, et al. Prognosis in relation to symptom duration in colon cancer. Br J Surg. 1981; 68: 846–849.PubMedCrossRefGoogle Scholar
  6. 6.
    Goldman L. Cardiac risks and complications of noncardiac surgery. Ann Intern Med. 1983; 98: 504–513.PubMedGoogle Scholar
  7. 7.
    Griffith RS. Preoperative evaluation: medical obstacles to surgery. Cancer. 1992; 70: 1333–1341.PubMedCrossRefGoogle Scholar
  8. 8.
    Freeny PC, Marks WM, Ryan JA, et al. Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence. Radiology. 1986; 158: 347–353.PubMedGoogle Scholar
  9. 9.
    Collier BD, Abdel-Nabi H, Doerr RJ. Immunoscintigraphy performed with IN-111-labeled CYT-103 in the management of colorectal cancer. Comparison with CT. Radiology. 1992; 185: 179–186.PubMedGoogle Scholar
  10. 10.
    DeVita VT, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. 3rd ed. Philadelphia: JB Lippincott; 1989.Google Scholar
  11. 11.
    Ozoux JP, deCalan L, Perrier M, et al. Surgery for carcinoma of the colon in people aged 75 years and older. Int J Colorect Dis. 1990; 5: 25–30.CrossRefGoogle Scholar
  12. 12.
    Zieren HU, Muller JM, Zieren J. Resection of colorectal liver metastases in old patients. Hepatogastroenterology. 1994; 41: 34–37.PubMedGoogle Scholar
  13. 13.
    Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985; 312: 1465–1472.Google Scholar
  14. 14.
    Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy of radiation therapy for rectal cancer: results form NSABP protocol R-01. J Natl Cancer Inst. 1988; 80: 21–29.PubMedCrossRefGoogle Scholar
  15. 15.
    Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med. 1991; 324: 709–715.PubMedCrossRefGoogle Scholar
  16. 16.
    Steele G. Combined-modality therapy for rectal carcinoma -the time has come. N Engl J Med. 1991; 324: 764–766.PubMedCrossRefGoogle Scholar
  17. 17.
    Glimelius B, Pahlman L. The value of adjuvant therapy after radical surgery for colorectal cancer. Ann Med. 1992; 24: 9–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Stockholm Rectal Cancer Study Group. Preoperative short term radiation in operable rectal carcinoma. A prospective randomized trial. Cancer. 1990; 66: 49–55.Google Scholar
  19. 19.
    Schilsky RL, Brachman DG. Adjuvant chemotherapy and radiation therapy in colorectal cancer. PPO Updates. 1992; 6: 1–12.Google Scholar
  20. 20.
    Wolmark N, Rockette H, Fisher B, et al. Leukovorinmodulated 5-FU(LV-FU) as adjuvant therapy for primary colon cancer: NSABP C-03. Proc Am Soc Clin Oncol. 1993; 12: 578.Google Scholar
  21. 21.
    Hoover HC, et al. Five year follow up of a controlled trial of active specific immunotherapy in colorectal cancer. Proc Am Soc Clin Oncol. 1990; 9: 106.Google Scholar
  22. 22.
    Moertel CG, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990; 322: 352–358.PubMedCrossRefGoogle Scholar
  23. 23.
    Adjuvant therapy for patients with colon and rectum cancer. Clin Courier 1990, November; 8(10).Google Scholar
  24. 24.
    Brower M, Asbury R, Kramer Z, et al. Adjuvant chemotherapy for colorectal cancer in the elderly: population based experience. ASCO Proc. 1993; 12: 195.Google Scholar
  25. 25.
    Witzig TE, et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer. 1991; 68: 879–888.PubMedCrossRefGoogle Scholar
  26. 26.
    Patt YZ. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues. J Clin Oncol. 1993; 11: 815–819.PubMedGoogle Scholar
  27. 27.
    Kohne-Wompner CH, Schmoll HJ, Harstrick A, Rusturn YM. Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials. Semin Oncol. 1992; 19: 105–125.PubMedGoogle Scholar
  28. 28.
    Vaughn DJ, Haller DG. Nonsurgical management of recurrent colorectal cancer. Cancer. 1993; 71: 4278–4293.PubMedCrossRefGoogle Scholar
  29. 29.
    Manton KG, Stallard E. Cross-sectional estimates of active life expectancy for the U.S. elderly and oldest-old populations. J Gerontol. 1991; 46 (suppl): 170–182.Google Scholar
  30. 30.
    Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J. 1993; 306: 752–755.CrossRefGoogle Scholar
  31. 31.
    Meyers WC, Damaino RJ, Postlethwait RW, et al. Adenocarcinoma of the stomach: changing patterns over et al. Serum testosterone: dihydrotestosterone ratio and the last four decades Ann Surg. 1987;205:1–8 Google Scholar
  32. 32.
    Weiman TJ, Max MH, Volges CR, et al. Diversion of duodenal contents: its effect on the production of experi- gastric cancer. Arch Surg. 1980; 115: 959–961.CrossRefGoogle Scholar
  33. 33.
    Hitchock CR, Schneider SL. Early diagnosis of gastric cancer. Surg Gynecol Obstet. 1961; 113: 655.Google Scholar
  34. 34.
    Gobbi PG, Diongi P, Barbieri F, Corbella F, et al. The role of surgery in the multimodal treatment of primary gastric non-Hodgkin’s lymphoma. Cancer. 1990; 65: 2528–2536.Google Scholar
  35. 35.
    Higgins GA, Serlin O, Amadeo JH, et al. Gastric cancer factors in survival. Surg Gastrointest. 1976; 10: 393.Google Scholar
  36. 36.
    Beahrs GS, Henson DE, Hutter RVP, et al. Manual for canStaging of Cancer. Philadelphia: WB Saunders; 1993: 63–71Google Scholar
  37. 37.
    Smith JW, Brennan MF, et al. Preoperative endoscopic ultrasound can predict the risk of recurrence after opera cancer of the esophagus. Cancer. 1961; 14: 389–413.CrossRefGoogle Scholar
  38. 38.
    Cook AO, Levine BA, Sirinek KR, et al. Evaluation of gastric adenocarcinoma: abdominal computer tomography does not replace celiotomy. Arch Surg. 1986; 121: 603–606.Google Scholar
  39. 39.
    Kaneko K, Nakamura T, Umeda N, et al. Outcome of gastric carcinoma detected by gastric survey. Gut 1977;18:626–630.Google Scholar
  40. 40.
    Dalton RR, Eisenberg BL. Rationale for the current sur gical management of gastric adenocarcinoma. Oncology. 1994; 8: 99–104.PubMedGoogle Scholar
  41. 41.
    Gouzi JL, Huguier M, Faginiez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric an trum: a French prospective controlled trial. 1989; 209: 162–166.Google Scholar
  42. 42.
    Fujimoto S, Takahashi M, Ohkubo H, et al. Comparative clinicopathologic features of early gastric cancer in and older patients. Surgery. 1994; 115: 516–520.PubMedGoogle Scholar
  43. 43.
    Cullinan SA, Moertel CG, Fleming TR, et al. A comparison of 3 chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma: vs fluorouracil, doxorubicinand mitomycin. JAMA. 1985; 253: 2061–2067.PubMedCrossRefGoogle Scholar
  44. 44.
    Wilke H, Preusser P, Fink U, et al. High dose folinic acid/ etoposide/5-fluorouracil in advanced gastric cancer-a phase II study in elderly patients or patients with cardiacr isk. Invest New Drugs. 1990; 8: 65–70.PubMedCrossRefGoogle Scholar
  45. 45.
    The Gastrointestinal Study Group. The concept of locally advanced gastric cancer: effect of treatment on outcome. Cancer 1990; 66: 2322–2330.Google Scholar
  46. 46.
    Moertel C, Childs DS, O’Fallon JR, et al. 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric cancer. J Clin Oncol 1984;2:Google Scholar
  47. 47.
    Ghadirian P, Simard A, Baillargeon J. Tobacco, alcohol and coffee and cancer of pancreas. Cancer. 1991; 67: 2664 2670.Google Scholar
  48. 48.
    Farrow DC, Davis S. Diet and the risk of pancreatic in men. Am J Epidemiol. 1990; 132: 422–431Google Scholar
  49. 49.
    Offerhaus GJA, Tersmette AC, Tersmette KWF, et al. Gastric, pancreatic, and colorectal carcinogenesis following remote peptic ulcer surgery. Mod Pathol 1988; 1: 352–356.PubMedGoogle Scholar
  50. 50.
    Moertel CG. An odyssey in the land of small tumors. J Clin. Oncol 1987; 5: 1503–1522.Google Scholar
  51. 51.
    Robles-Diaz G, Diaz-Sanchez V, Fernandez-delCastillo C, CA 19–9 in the diagnosis of pancreatic cancer. Am J Gastroenterol. 1991; 86: 591–594.PubMedGoogle Scholar
  52. 52.
    Balthazar EJ, Chako AC. Computed tomography of panmental creatic masses. Am J Castroenterol. 1990; 85: 343–349.Google Scholar
  53. 53.
    Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater Ann Surg1935;102 Google Scholar
  54. 54.
    Saltzberg D, Foley K. Management of pain in pancreatic cancer. Surg Clin North Am. 1989; 69: 629–649.Google Scholar
  55. 55.
    Ilson DH, Kelson DP. Adjuvant postoperative therapy of gastrointestinal malignancies. Oncology. 1994; 8: 75–95.PubMedGoogle Scholar
  56. 56.
    Kelson D. Neoadjuvant therapy for gastrointestinal. cers. Oncology. 1993; 7: 25–32.Google Scholar
  57. 57.
    Wynder AR, Bross LJ. A study of the etiologic factors in tion for gastric carcinoma. J Clin Oncol. 1993; 11: 2380–2385.Google Scholar
  58. 58.
    Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus. DAMA. 1991; 265: 1287–1289.Google Scholar
  59. 59.
    Cameron AJ, Ott BJ, Payne WS. Incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med. 1985; 313: 857–859.PubMedCrossRefGoogle Scholar
  60. 60.
    Earlem R. An MRC prospective randomized trial of radiotherapy versus surgery for operable squamous cell carcinoma of the esophagus.Ann R Coll Surg Engl 1991; 73: 8–12.Google Scholar
  61. 61.
    Caspers RJ, Welvaart K, Verkes RJ, et al. The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother Oncol. 1988; 12: 15–23.PubMedCrossRefGoogle Scholar
  62. 62.
    Pakisch B, Kohek P, Poier E, et al. Iridium-192 high dose brachytherapy combined with external beam irradiation younger in non-resectable oesophageal cancer. Clin Oncol. 1993; 5: 154–158.CrossRefGoogle Scholar
  63. 63.
    Anderson LL, Lad TE. Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer. 1982; 50: 1587–1590.PubMedCrossRefGoogle Scholar
  64. 64.
    Philip PA, Ajani JA. Has combination modality therapy improved the outlook in carcinoma of the esophagus? Oncology. 1994; 8: 37–44.PubMedGoogle Scholar
  65. 65.
    Leichman L, Berry BT. Experience with cisplatin in treat-ment regimens for esophageal cancer. Semin Oncol. 1991; 18: 64–72.PubMedGoogle Scholar
  66. 66.
    Thyss A, Saudes JO, Creisson MH, et al. Renal tolerance of cisplatin in patients more than 80 years old. J Clin Oncol. 1994; 12: 2121–2125.PubMedGoogle Scholar
  67. 67.
    Ajani JA, Roth JA, Ryan MB, et al. Intensive preoperative Combined chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 1993; 11: 22–28.PubMedGoogle Scholar
  68. 68.
    Doyle D, Hanks WC, MacDonald N. In: The Oxford Text-, book of Palliative Medicine. Oxford: Oxford University.Press; 1993.Google Scholar
  69. 69.
    Sharfman W, Walsh D. Has the analgesic efficacy of cancer neurolytic celiac plexus block been demonstrated in pan creatic cancer? Pain. 1990; 41: 267–271.PubMedCrossRefGoogle Scholar
  70. 70.
    Management of Cancer Pain. AHCPR Pub. ©94–0592. Rockville, MD: U.S. Dept. of Health and Human Services; March, 1994.Google Scholar
  71. 71.
    Mercadante S. The role of octreotide in palliative care J Pain Symptom Manage. 1994; 9: 406–411.PubMedCrossRefGoogle Scholar
  72. 72.
    Ashby MA, Game PA, Britten-Jones R, et al. Percutane- Canous gastrostomy as a venting procedure in palliative care. cer. Pallias Med. 1991; 5: 147–150.Google Scholar
  73. 73.
    Doberneck R, Berndt G. Delayed gastric emptying after palliative gastrojejunostomy for carcinoma of the pancreas Arch Surg. 1987; 122: 827–829.PubMedCrossRefGoogle Scholar
  74. 74.
    Van den Bosch RP, van den Schelling GP, Klinbenbilj JHG, et al. Guidelines for the application of surgery and endoprosthesis in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg. 1994; 219: 18–24.PubMedCrossRefGoogle Scholar
  75. 75.
    Twycross RG, Lack SA. In: Therapeutics in Terminal London: Churchill -Livingstone; 1990.Google Scholar
  76. 76.
    Alexander HR, Norton JA. Pathophysiology of cancer cachexia. In: Doyle D, Hanks WC, MacDonald N, eds. The.Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press; 1993: 316–329.Google Scholar
  77. 77.
    Breura E, Fainsinger R. Clinical management of cachexia and anorexia. In: Doyle D, Hanks WC, MacDonald N, eds. The Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press; 1993: 330–337.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Walter B. Forman

There are no affiliations available

Personalised recommendations